|
XL One
An effective combination of ceftriaxone and Sulbactam. Ceftriaxone is a 3rd
generation cephalosporin which interferes with the biosynthesis of
peptidoglycan component of the bacterial cell wall. Sulbactam in XL One is a
broad spectrum Beta Lactamase inhibitor that lowers the MIC and MBC values of
ceftriaxone producing synergistic effect. XL One is clinically very effective
in serious infections and is available as XL One 1.5 gms, XL One 0.750 mg and
XL One 0.375 mg.
CA 007
CA 007 is the first fixed dose combination of a fourth generation broad spectrum
cephalosporin cefepime and amikacin the highly accepted aminoglycoside. CA 007
is superior to individually administered cefipime and amikacin in terms of
plasma concentration and superior zone of inhibition thus ensuring good clinical
response and also has established safety in comparision to individually
administered cefipime and amikacin. CA 007 is highly effective against
Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, E coli and
other tough pathogens which are seen in serious life threatening infections. CA
007 is available as CA 007 2.5 gms, CA 007 1.25 gms and CA 007 0.625 gms for
varying needs.
Zoom
A combination of cefepime 1gm and Tazobactum 125 mg. Cefepime is a fourth
generation Cephalosporin which is effective against gram +ve and gram –ve
pathogens, whereas Tazobactam is a beta-lactamase inhibitor and maintains the
efficacy of cefepime by preventing the destruction of cefepime by ESBLs.
Merom
Merom is meropenem injection the carbapenem group of antibiotic.Merom is a life saving drug and is very reliable antibiotic, Merom has ultra-broad spectrum activity against both Gram-positive and Gram-negative aerobes and anaerobes. Merom is highly stable to ESBLs (Extended Spectrum Betalactamases) and is effective against all known ESBLs (more than 200 ESBLs are known). Unlike imipenem, it is not inactivated by human renal dehydropeptidase-1 (DHP-1) and hence does not require concomitant administration of DHP-1 inhibitor such as cilastatin. Merom has no convulsive potential unlike imepenem.
Merom is available as Merom 1gm and Merom 0.5 gm vials.
Ximclav
Ximclav contains cefixime along with clavulanate. Ximclav is the first
cefixime brand with clavulanate to be introduced in India by Themis Medicare.
It covers gram +ve and gram –ve bacteria. Clavulanate in Ximclav inhibits the
action of beta lactamases and restores the full activity of cefixime. Ximclav
is available as Ximclav 200 mg, Ximclav 100mg and Ximclav 50 mg.
AZAD
Azad is azithromycin, the macrolide group of antibiotic, which is bactericidal
with wide coverage of gram +ve and gram –ve microorganisms. It blocks
transpeptidation by binding to 5OS subunits of bacterial ribosomes and thus
inhibits protein synthesis of bacteria. It is useful in treatment of
susceptible infections including M. avium, uncomplicated genital infections,
skin and soft tissue infections and respiratory infections. Azad is available
as Azad 500 mg and 250 mg tablets and for paediatric use Azad 100mg and Azad
200 mg suspension are ideal.
Sepgard Gel:
Sepgard Gel, ideal for wound care, contains Feracrylum which is an original
research molecule of Themis Medicare. Feracrylum is a unique molecule
exhibiting haemostatic, antimicrobial and hygroscopic properties. Feracrylum
in Sepgard combines with blood proteins, especially albumin and forms a
gel-like substance, which forms a physical barrier on wound surface and stops
capillary bleeding and oozing. This haemostatic action does not interfere with
body’s natural process of blood coagulation.
Feracrylum exerts its antimicrobial action by breaking the cell wall and ejecting out the cell mass of the microorganisms. It is effective against all common Gram positive and Gram negative bacteria and common pathogenic fungi found in wound.
Its hygroscopic property maintains moist environment on the wound surface and thus facilitates healthy granulation. It also helps in relatively painless removal of dressing.
Thus Sepgard Gel is the most ideal for the treatment of all wounds like traumatic wounds, decubitus wounds, cuts, chemical and thermal burns, post-operative wounds and episiotomy wounds.
The colourless, odourless gel ensures patient compliance. As it is not absorbed, it is without any systemic side effects.
Sepgard Solution:
It contains feracrylum, the original research formulation of Themis Medicare (for more information, please see Sepgard Gel)
It is the ideal haemostatic agent for intra and post-operative local application. It effectively reduces blood loss during surgery and offer clear field of surgery. Because of it antimicrobial action, it prevents post-operative infection.
Sepgard Tulle:
It is the original research formulation of Themis Medicare for painless dressing. Sepgard Tulle is sterile, ready to use, non-adherent dressing for wounds. It consists of cotton gauze evenly impregnated with polyethylene glycol base containing feracrylum 3% w/w. (for more information on Feracrylum, please see Sepgard Gel). Apart from painless dressing, it provides antimicrobial action and haemostatic action. It is the most ideal for donor and recipient site during skin grafting, burns dressing, postoperative dressing and dressing of wounds.
Sepgard AR Gel:
It is a research formulation of Themis Medicare Limited. Sepgard AR Gel is a
unique combination of centbucridine and feracrylum, the two research molecules
of Themis Medicare Limited. It is indicated in the treatment of haemorrhoides,
anal fissures and proctitis. Centbucridine in Sepgard AR gel exerts anaesthetic
action and thus reduces pain, produces vasoconstriction and thereby reduces
bleeding and reduces itching by its antihistaminic action. Feracrylum due to its
haemostatic action reduces bleeding and due to its antimicrobial action prevents
infections.
|
